PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
0.81%
Revenue growth below 50% of CRWV's 23.55%. Michael Burry would check for competitive disadvantage risks.
90.99%
Cost growth above 1.5x CRWV's 19.16%. Michael Burry would check for structural cost disadvantages.
-13.92%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
-14.61%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
27.60%
R&D change of 27.60% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.71%
Operating expenses reduction while CRWV shows 17.97% growth. Joel Greenblatt would examine advantage.
8.78%
Total costs growth less than half of CRWV's 18.28%. David Dodd would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
16.77%
D&A growth 50-75% of CRWV's 26.15%. Bruce Berkowitz would examine asset strategy.
-4.77%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
93.10%
EBITDA margin growth exceeding 1.5x CRWV's 7.69%. David Dodd would verify competitive advantages.
-8.24%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-8.98%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
-501.97%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-97.32%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-97.34%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-97.27%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-97.35%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-97.37%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-97.83%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-97.73%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
0.82%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
0.14%
Diluted share reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.